Meluzín J, Lupínek Z, Novák M, Rotrekl P
Vnitr Lek. 1989 Nov;35(11):1062-71.
In 21 patients with chronic stable angina pectoris stage II-III according to NYHA, by means of bicycle ergometry antianginous and antiischaemic effects of short-term dilthiazem administration (Blocalcin 60, Lachema) were compared with isradipine (Lomir, Sandoz). Dilthiazem was administered in three doses à 90 mg by mouth (midday, evening and subsequent morning), isradipine in a similar way but in three doses à 5 mg. Both preparations reduced, as compared with placebo, significantly the systolic and diastolic blood pressure at rest and the diastolic pressure during a load, dilthiazem also the systolic pressure during a load. Both drugs raised also significantly the total amount of work performed during an ergometric examination, dilthiazem moreover delayed significantly the onset of stenocardia and significantly reduced the ST depression in lead V5 during the maximal load achieved with all administered drugs. A significant increase of the heart rate at rest and in particular of the heart rate during an equal maximal load after isradipine or after placebo, but in particular after dilthiazem, led in comparison with dilthiazem to a significant rise of Robinson's index during the same maximum load and was obviously the cause of its lower anti-anginous and antiischaemic effectiveness. Tachycardia at rest and after a load following isradipine administration led in four patients to a deteriorated load tolerance, as compared with placebo, in another patient tachycardia caused stenocardia at rest with ST depressions on the electrocardiographic tracing. Based on the assembled results, it seems better and safer to use in the treatment of chronic stable angina pectoris dilthiazem rather than isradipine.
对于21例根据纽约心脏协会(NYHA)分级处于II - III级的慢性稳定型心绞痛患者,通过自行车测力计比较了短期服用地尔硫䓬(博利康尼60,拉赫玛)和伊拉地平(洛米,山德士)的抗心绞痛和抗缺血作用。地尔硫䓬口服给药,分三次,每次90毫克(中午、晚上及次日早晨);伊拉地平给药方式类似,但分三次,每次5毫克。与安慰剂相比,两种制剂均显著降低静息时的收缩压和舒张压以及负荷时的舒张压,地尔硫䓬还降低负荷时的收缩压。两种药物还显著提高了测力计检查期间的总工作量,此外,地尔硫䓬显著延迟了心绞痛的发作,并在所有给药药物达到的最大负荷期间显著降低了V5导联的ST段压低。与地尔硫䓬相比,伊拉地平或安慰剂后静息心率显著增加,尤其是在同等最大负荷时心率增加,特别是地尔硫䓬后,导致在相同最大负荷期间罗宾逊指数显著升高,这显然是其抗心绞痛和抗缺血效果较低的原因。与安慰剂相比,伊拉地平给药后静息及负荷后的心动过速使4例患者的负荷耐受性恶化,在另一例患者中,心动过速导致静息时心绞痛伴心电图ST段压低。根据汇总结果,在慢性稳定型心绞痛的治疗中,使用地尔硫䓬似乎比伊拉地平更好、更安全。